Biohit Oyj — Director's Dealing 2021

Feb 23, 2021

Biohit Oyj Managers' Transactions

Biohit Oyj Managers' Transactions

23 February 2021 at 10.00 am local time (EET)

Biohit Oyj: Managers' Transactions
Person subject to the notification requirement
Name:                                    Semi Korpela
Position:                                Chief Executive Officer
Issuer:                                   Biohit Oyj
LEI:                                        74370089ATTSNBXJVT29
__________________________________________________
Notification type:                 INITIAL NOTIFICATION
Reference number:              74370089ATTSNBXJVT29_20210222152942_7
Transaction date:                 2021-02-19
Venue:                                   NASDAQ HELSINKI LTD (XHEL)

Nature of the transaction:    DISPOSAL
Instrument type:                    SHARE

ISIN:                                        FI0009005482
Transaction details
Volume: 6,217
Unit price: 2.1559 EUR
Aggregated transactions
Volume: 6,217
Volume weighted average price: 2.1559 EUR

Biohit Oyj
Semi Korpela
CEO
For additional information:
CEO Semi Korpela,
Biohit Oyj
p. +358 9 773 861
investor.relations@biohit.fi
www.biohit.fi

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s
mission is “Innovating for Health” – we produce innovative products and services
to promote research and early diagnosis. Biohit is headquartered in Helsinki,
Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share
(BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.
www.biohithealthcare.com